Christopher Flowers, MD, MS
Articles
Polatuzumab Vedotin Regimen Yields ‘Meaningful’ Benefit in DLBCL, Expert Says
April 19th 2023Polatuzumab vedotin-piiq plus R-CHP can reduce the need for any subsequent lines of therapy for patients with diffuse large B-cell lymphoma, according to an expert from The University of Texas MD Anderson Cancer Center.
The Role of the Comprehensive Geriatric Assessment in the Evaluation of the Older Cancer Patient
Carmelo Blanquicett, MD, PhD, FACP;Theodore Johnson, II, MD, MPH;Christopher Flowers, MD, MS;Jonathon B. Cohen, MD, MS
November 14th 2019Geriatric assessments have now been recommended as part of the standard evaluation of an older adult considering cancer therapy.
Latest Updated Articles
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: May 17th 2013 | Updated: December 22nd 2024
Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
Published: December 1st 2016 | Updated: December 22nd 2024
Patient With History of COPD Presents With Abdominal Pain
